Published

Consistency of protocol and safety data reporting in clinical trial registrations and corresponding publications of interventions involving MDMA and psilocybin

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Journal of Clinical Epidemiology
Date: 2026-04-01
Source: Crossref
DOI: 10.1016/j.jclinepi.2026.112170
PubMed: 41581835

Authors

Žuljević Marija Franka Mijatović Antonija Orhanović Renata Goasdoué Glenn Gujinović Diana

Watch author

Derived topics and classifications

psilocybin Clinical Trial Safety Clinical Trial

Citation graph

35 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

10.1097/jcp.0b013e3182305656 10.1007/s00213-017-4713-7 10.1080/02791072.2014.877322 10.1016/j.jns.2020.116715 10.1007/s00213-024-06598-6 10.1007/s00213-022-06123-7 10.1021/acschemneuro.3c00692 10.1176/appi.ajp.2019.19010035 10.3949/ccjm.92a.24032 10.2147/dddt.s443177 10.1146/annurev-psych-020124-023532 10.3389/fpsyg.2020.01681

Indexed papers citing this DOI

Consistency of protocol and safety data reporting in clinical trial registrations and corresponding publications of interventions involving MDMA and psilocybin2026-04-01

Related papers

No close related records were found yet.